These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7838129)

  • 21. Anomalous effects of external TEA on permeation and gating of the A-type potassium current in H. aspersa neuronal somata.
    Denton JS; Leiter JC
    J Membr Biol; 2002 Nov; 190(1):17-28. PubMed ID: 12422269
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the outer pore region of the apamin-sensitive Ca2+-activated K+ channel rSK2.
    Jäger H; Grissmer S
    Toxicon; 2004 Jun; 43(8):951-60. PubMed ID: 15208028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel enhancing effect of clofilium on transient outward-type cloned cardiac K+ channel currents.
    Kobayashi T; Mikala G; Yatani A
    Br J Pharmacol; 1995 Mar; 114(6):1222-6. PubMed ID: 7620712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tityustoxin-K(alpha) blockade of the voltage-gated potassium channel Kv1.3.
    Rodrigues AR; Arantes EC; Monje F; Stühmer W; Varanda WA
    Br J Pharmacol; 2003 Jul; 139(6):1180-6. PubMed ID: 12871837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo targeting of ERG potassium channels in mice and dogs by a positron-emitting analogue of fluoroclofilium.
    Kim SW; Yang SD; Ahn BJ; Park JH; Lee DS; Gessner G; Heinemann SH; Herdering W; Yu KH
    Exp Mol Med; 2005 Aug; 37(4):269-75. PubMed ID: 16155403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of fluoxetine block of cloned voltage-activated potassium channel Kv1.3.
    Choi JS; Hahn SJ; Rhie DJ; Yoon SH; Jo YH; Kim MS
    J Pharmacol Exp Ther; 1999 Oct; 291(1):1-6. PubMed ID: 10490879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of permeant and blocking ions in cloned inward-rectifier K+ channels.
    Oliver D; Hahn H; Antz C; Ruppersberg JP; Fakler B
    Biophys J; 1998 May; 74(5):2318-26. PubMed ID: 9591659
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blockade of delayed rectifier K+ currents in neuroblastoma x glioma hybrid (NG 108-15) cells by clofilium, a class III antidysrhythmic agent.
    Reeve HL; Peers C
    Br J Pharmacol; 1992 Feb; 105(2):458-62. PubMed ID: 1559135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells.
    Hahn SJ; Wang LY; Kaczmarek LK
    Neuropharmacology; 1996; 35(7):895-901. PubMed ID: 8938720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for novel drug effects with a microphysiometer: a potent effect of clofilium unrelated to potassium channel blockade.
    Rabinowitz JD; Rigler P; Carswell-Crumpton C; Beeson C; McConnell HM
    Life Sci; 1997; 61(7):PL87-94. PubMed ID: 9252253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. External nickel blocks human Kv1.5 channels stably expressed in CHO cells.
    Perchenet L; Clément-Chomienne O
    J Membr Biol; 2001 Sep; 183(1):51-60. PubMed ID: 11547352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement, block, and modulation of potassium channel currents in the heart.
    Arena JP; Walsh KB; Kass RS
    Prog Clin Biol Res; 1990; 334():43-63. PubMed ID: 2309009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Block by 4-aminopyridine of a Kv1.2 delayed rectifier K+ current expressed in Xenopus oocytes.
    Russell SN; Publicover NG; Hart PJ; Carl A; Hume JR; Sanders KM; Horowitz B
    J Physiol; 1994 Dec; 481 ( Pt 3)(Pt 3):571-84. PubMed ID: 7707226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiarrhythmic drugs, clofilium and cibenzoline are potent inhibitors of glibenclamide-sensitive K+ currents in Xenopus oocytes.
    Sakuta H; Okamoto K; Watanabe Y
    Br J Pharmacol; 1993 Jul; 109(3):866-72. PubMed ID: 8358576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of clofilium, a K-channel blocker, on the electrogenic K secretion and the sensory discharge at the frog semicircular canal.
    Rossi ML; Ferrary E; Martini A; Martini M; Pelucchi B; Bernard C; Teixeira M; Sterkers O; Fesce R
    Brain Res; 1996 May; 721(1-2):174-80. PubMed ID: 8793098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcineurin-independent inhibition of KV1.3 by FK-506 (tacrolimus): a novel pharmacological property.
    Ahn HS; Kim SE; Choi BH; Choi JS; Kim MJ; Rhie DJ; Yoon SH; Jo YH; Kim MS; Sung KW; Kwon OJ; Hahn SJ
    Am J Physiol Cell Physiol; 2007 May; 292(5):C1714-22. PubMed ID: 17166943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determinants of antiarrhythmic drug action. Electrostatic and hydrophobic components of block of the human cardiac hKv1.5 channel.
    Snyders DJ; Yeola SW
    Circ Res; 1995 Sep; 77(3):575-83. PubMed ID: 7641327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concomitant acceleration of the activation and inactivation kinetics of the human delayed rectifier K+ channel (Kv1.1) by Ca(2+)-independent phospholipase A2.
    Gubitosi-Klug RA; Yu SP; Choi DW; Gross RW
    J Biol Chem; 1995 Feb; 270(7):2885-8. PubMed ID: 7852365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple binding sites for melatonin on Kv1.3.
    Varga Z; Panyi G; Péter M; Pieri C; Csécsei G; Damjanovich S; Gáspár R
    Biophys J; 2001 Mar; 80(3):1280-97. PubMed ID: 11222291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic and bradycardic drugs inhibit currents of cloned K+ channels, KV1.2 and KV1.4.
    Yamagishi T; Ishii K; Taira N
    Eur J Pharmacol; 1995 Aug; 281(2):151-9. PubMed ID: 7589202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.